[1]丁汉文,陈 勇,王 倩,等.卡替洛尔联合匹多康液体敷料治疗浅表型婴幼儿血管瘤的临床研究[J].中国美容医学,2024,(6):65-68.
 DING Hanwen,CHEN Yong,WANG Qian,et al.Clinical Study on Carteolol Combined with Pidokon Liquid Dressing in the Treatment of Superfi cial Infantile Hemangioma?/html>[J].Medical Aesthetics and Beauty,2024,(6):65-68.
点击复制

卡替洛尔联合匹多康液体敷料治疗浅表型婴幼儿血管瘤的临床研究()
分享到:

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2024年6期
页码:
65-68
栏目:
出版日期:
2024-05-31

文章信息/Info

Title:
Clinical Study on Carteolol Combined with Pidokon Liquid Dressing in the Treatment of Superfi cial Infantile Hemangioma?/html>
文章编号:
1008-6455(2024)06-0065-03
作者:
丁汉文陈 勇王 倩王 慜袁斯明
(南京医科大学附属金陵医院烧伤整形科 江苏 南京 210000 )
Author(s):
DING Hanwen CHEN Yong WANG Qian WANG Min YUAN Siming
( Department of Burn and Plastic Surgery, Jinling Hospital, Nanjing Medical University, Nanjing 210000, Jiangsu, China )
关键词:
卡替洛尔婴幼儿血管瘤匹多康液体敷料外用
Keywords:
Carteolol infantile hemangioma pidokon liquid dressing topical
分类号:
R729
文献标志码:
A
摘要:
目的:探讨应用卡替洛尔联合匹多康液体敷料治疗浅表型婴幼儿血管瘤的效果。方法:回顾性分析2016年1月-2021年 12 月在笔者科室接受卡替洛尔联合匹多康液体敷料外涂治疗的23例浅表型婴幼儿血管瘤患儿的临床资料。治疗方法为每次外 敷时间90 min,一日3次,持续6~12个月。治疗后将患儿疗效分为三级进行评定:Ⅰ级,治疗无效,需改用其他治疗方法; Ⅱ级,控制瘤体生长;Ⅲ级,促进瘤体消退。结果:23例进行上述治疗的患儿中,Ⅲ级患儿达16例,其中完全消退或仅残留 毛细血管扩张的有5例;Ⅱ级3例;Ⅰ级4例。湿疹和溃疡为常见局部不良反应。结论:卡替洛尔联合匹多康液体敷料外用治 疗浅表型婴幼儿血管瘤有较好效果。?/html>
Abstract:
Objective To investigate the therapeutic effect of topical Carteolol combined with pidokon liquid dressing on superfi cial infantile hemangioma. Methods From January 2016 to December 2021,Carteolol combined with pidokon liquid dressing was given to 23 patients with superfi cial infantile hemangioma for three times a day for 90 minutes each time. The duration of the treatment was six to twelve months. After treatment, the therapeutic eff ects were grade as: grade Ⅰ(unable to control the growth of the hemangioma),Ⅱ(the growth of the hemangioma was arrested), Ⅲ(hemangioma significantly involuted). Results In the 23 children who underwent these treatments,there were four patients of gradeⅠ,three patients of grade Ⅱ,sixteen patients of grade Ⅲ. Complete clearance was achieved in fi ve patients. Eczema and ulcer were common local adverse reactions. Conclusion In the treatment of superfi cial infantile hemangioma during proliferative phase ,topical applying of Carteolol combined with pidokon liquid dressing presents good clinical effi cacy.

相似文献/References:

[1]邹 筠,袁 华,付荣华,等.普萘洛尔治疗婴幼儿血管瘤时机选择及安全性评估的临床研究[J].中国美容医学,2019,(06):78.
 ZOU Yun,YUAN Hua,FU Rong-hua,et al. Clinical Study on Timing and Safety Evaluation of Propranolol in Treatment of Infant Hemangioma[J].Medical Aesthetics and Beauty,2019,(6):78.
[2]徐筑秋 综述,杨晓楠 祁佐良 审校. 西罗莫司治疗卡波西形血管内皮瘤的研究进展[J].中国美容医学,2019,(08):155.
 XU Zhu-qiu,YANG Xiao-nan,QI Zuo-liang. Research Progress of Sirolimus in Kaposiform Hemangioendothelioma Treatment[J].Medical Aesthetics and Beauty,2019,(6):155.
[3] 张宇飞,刘晋灵,王 博,等. 普萘洛尔联合其他治疗措施治疗婴幼儿血管瘤有效率的网状Meta分析[J].中国美容医学,2020,(5):27.
  ZHANG Yu-fei,LIU Jin-ling,WANG Bo,et al. Effi cient of Propranolol Combined with Other Therapy in the Treatment of InfantileHemangiomas:A Network Meta-analysis[J].Medical Aesthetics and Beauty,2020,(6):27.
[4] 魏 娜,赵东红,李 江. 普萘洛尔口服联合复方倍他米松注射治疗婴幼儿血管瘤的护理配合探讨[J].中国美容医学,2021,(7):165.
  WEI Na,ZHAO Dong-Hong,LI Jiang. Nursing Experience of Infantile Hemangioma by Intralesional Injection of PropranololCombined with Compound Betamethasone[J].Medical Aesthetics and Beauty,2021,(6):165.
[5] 王 攀,郑源泉,卢静静,等. 2%卡替洛尔滴眼液联合脉冲染料激光治疗婴儿血管瘤疗效及安全性研究[J].中国美容医学,2021,(8):72.
  WANG Pan,ZHENG Yuan-quan,LU Jing-jing,et al. Efficacy and Safety of 2% Cartilolol Solution Combined with Pulsed Dye Laser (595nm)in the Treatment of Infant Hemangiomas[J].Medical Aesthetics and Beauty,2021,(6):72.
[6]孙 恒,倪志福,屈振繁.两种给药方式治疗婴幼儿血管瘤疗效对比研究[J].中国美容医学,2021,(12):86.
 SUN Heng,NI Zhi-fu,QU Zhen-fan.Clinical Comparative Study of Two Drug Administration Methods for Treatment of Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2021,(6):86.
[7]高倩倩 综述,霍 然审校.婴幼儿血管瘤治疗效果评分系统的研究进展[J].中国美容医学,2022,(7):172.
 GAO Qianqian,HUO Ran.Research Progress in Scoring the Therapeutic Effects of Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2022,(6):172.
[8]陈远征 陈昱岐 综述,白 南 审校.口服普萘洛尔治疗婴幼儿血管瘤临床应用新进展[J].中国美容医学,2023,(11):189.[doi:10.15909/j.cnki.cn61-1347/r.005980]
 CHEN Yuanzheng,CHEN Yuqi,BAI Nan.New Progress in Clinical Application of Oral Propranolol in the Treatment of Infantile Hemangioma[J].Medical Aesthetics and Beauty,2023,(6):189.[doi:10.15909/j.cnki.cn61-1347/r.005980]

更新日期/Last Update: 2024-06-04